Search research articles
Contact Us
Filters
Showing results (811-820 of 815) with videos related to
Page
of 82
Sort By:
You have reached the last page of results.
This site can display upto 815 results.
JCI Insight
|
June 21, 2022
Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling
Leila B Giron, Michael J Peluso, Jianyi Ding, et al.
Cancer Discovery
|
October 4, 2018
Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility
Amanpreet Kaur, Brett L Ecker, Stephen M Douglass, et al.
Plos Pathogens
|
February 19, 2026
Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization
Kylie M Konrath, Kevin Liaw, Nicholas J Tursi, et al.
Cancer Research
|
September 24, 2025
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
Michael Hulse, Min Wang, Chaoyi Xu, et al.
Nature
|
April 5, 2016
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
Amanpreet Kaur, Marie R Webster, Katie Marchbank, et al.
Page
of 82
Search research articles
Search
Showing results (811-820 of 815) with videos related to
Sort By:
Page
of 82
You have reached the last page of results.
This site can display upto 815 results.
JCI Insight
|
June 21, 2022
Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling
Leila B Giron, Michael J Peluso, Jianyi Ding, et al.
Cancer Discovery
|
October 4, 2018
Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility
Amanpreet Kaur, Brett L Ecker, Stephen M Douglass, et al.
Plos Pathogens
|
February 19, 2026
Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization
Kylie M Konrath, Kevin Liaw, Nicholas J Tursi, et al.
Cancer Research
|
September 24, 2025
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
Michael Hulse, Min Wang, Chaoyi Xu, et al.
Nature
|
April 5, 2016
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
Amanpreet Kaur, Marie R Webster, Katie Marchbank, et al.
Page
of 82